Rota virus vaccine, new notice

Folkehelseinstituttet

Folkehelseinstituttet [the Norwegian Institute of Public Health] is implementing an open tender competition for the procurement of vaccine against rota virus for the base vaccination of infants in the Norwegian child vaccination programme, starting up in Q2 2019. The competition is carried out as an open competitive tender, a one step process where all interested suppliers may submit a tender. Negotiations are not allowed. The objective of the procurement is to enter into a contract for the delivery of the rotavirus vaccine for base vaccination of infants in the Norwegian Child Vaccination Programme. The start of vaccination under the new agreement is anticipated to occur in Q2/Q3 2019. In addition to the information in KGV< the attached tender documentation provides information and rules for the competition.
The procurement was first announced on 1.6.2018 and then cancelled on 7.6.2018. The Doffin reference numbers to the cancelled competition are 2018-088615 and 2018-347723 respectively. The reasons for the cancellation are in the Doffin notice.

Frist

Fristen for mottak av tilbud var 2018-08-21. Anskaffelsen ble publisert 2018-06-14.

Leverandører

Følgende leverandører er nevnt i tildelingsbeslutninger eller andre anskaffelsesdokumenter:

Hvem? Hva? Hvor?
Anskaffelseshistorikk
Dato Dokument
2018-06-14 Kunngjøring av konkurranse
2018-12-13 Kunngjøring om tildeling av kontrakt
Kunngjøring av konkurranse (2018-06-14)
Gjenstand
Anskaffelsens omfang
Tittel: Vaccines
Referansenummer: 18/11059
Kort beskrivelse:
Folkehelseinstituttet [the Norwegian Institute of Public Health] is implementing an open tender competition for the procurement of vaccine against rota virus for the base vaccination of infants in the Norwegian child vaccination programme, starting up in Q2 2019. The competition is carried out as an open competitive tender, a one step process where all interested suppliers may submit a tender. Negotiations are not allowed. The objective of the procurement is to enter into a contract for the delivery of the rotavirus vaccine for base vaccination of infants in the Norwegian Child Vaccination Programme. The start of vaccination under the new agreement is anticipated to occur in Q2/Q3 2019. In addition to the information in KGV< the attached tender documentation provides information and rules for the competition. The procurement was first announced on 1.6.2018 and then cancelled on 7.6.2018. The Doffin reference numbers to the cancelled competition are 2018-088615 and 2018-347723 respectively. The reasons for the cancellation are in the Doffin notice.
Vis mer
Metadata for kunngjøring
Originalspråk: engelsk 🗣️
Dokumenttype: Kunngjøring av konkurranse
Kontraktens art: Varer
Forskrift: Det europeiske økonomiske samarbeidsområdet (EØS), med deltakelse av GPA-land
Felles innkjøpsordliste (CPV)
Kode: Vaksiner 📦
Tilleggs-CPV: Vaksiner 📦
Utførelsessted
NUTS-region: Norge 🏙️

Prosedyre
Prosedyretype: Åpen anbudskonkurranse
Tilbudstype: Innlevering for alle delkontrakter
Tildelingskriterier
Det mest økonomisk fordelaktige tilbudet

Oppdragsgiver
Identitet
Land: Norge 🇳🇴
Type tildelende myndighet: Departement eller annen nasjonal eller føderal myndighet
Navn på tildelende myndighet: Folkehelseinstituttet
Postadresse: Lovisenberggata 8
Postnummer: 0456
Poststed: Oslo
Kontakt
Internettadresse: http://www.fhi.no 🌏
E-post: ole.andreas.fuglesang@fhi.no 📧
Telefon: +47 21076629 📞
URL for dokumenter: http://eu.eu-supply.com/app/rfq/rwlentrance_s.asp?PID=213693&B=DFO 🌏
URL for deltakelse: http://eu.eu-supply.com/app/rfq/rwlentrance_s.asp?PID=213693&B=DFO 🌏

Referanse
Datoer
Sendt dato: 2018-06-14 📅
Innleveringsfrist: 2018-08-21 📅
Publiseringsdato: 2018-06-15 📅
Identifikatorer
Kunngjøringsnummer: 2018/S 113-258404
Refererer til kunngjøring: 2018/S 104-238612
OJ-S-utgave: 113
Tilleggsinformasjon
With reference to point II.2.7 about Duration etc. the Norwegian Institute of Public Health emphasises that the agreement duration of 48 months, is a maximum length, but the agreement can be terminated earlier in accordance with provisions in the Supply Agreement (the Contract) point 14. With reference to point II.2.6, the Norwegian Institute of Public Health emphasis that the stated value is the maximum value in a loosely estimated value range from NOK 48 million to NOK 74 million.
Vis mer

Gjenstand
Anskaffelsens omfang
Kort beskrivelse:
Folkehelseinstituttet [the Norwegian Institute of Public Health] is implementing an open tender competition for the procurement of vaccine against rota virus for the base vaccination of infants in the Norwegian child vaccination programme, starting up in Q2 2019. The competition is carried out as an open competitive tender, a one step process where all interested suppliers may submit a tender. Negotiations are not allowed. The objective of the procurement is to enter into a contract for the delivery of the rotavirus vaccine for base vaccination of infants in the Norwegian Child Vaccination Programme. The start of vaccination under the new agreement is anticipated to occur in Q2/Q3 2019. In addition to the information in KGV< the attached tender documentation provides information and rules for the competition.
Vis mer
The procurement was first announced on 1.6.2018 and then cancelled on 7.6.2018. The Doffin reference numbers to the cancelled competition are 2018-088615 and 2018-347723 respectively. The reasons for the cancellation are in the Doffin notice.
Estimert totalverdi: 74 000 000 NOK 💰
Kort beskrivelse:
Folkehelseinstituttet [the Norwegian Institute of Public Health] is implementing an open tender competition for the procurement of vaccine against rota virus for the base vaccination of infants in the Norwegian child vaccination programme, starting up in Q2 2019. The competition is carried out as an open competitive tender, a one step process where all interested suppliers may submit a tender. Negotiations are not allowed. The objective of the procurement is to enter into a contract for the delivery of the rotavirus vaccine for base vaccination of infants in the Norwegian Child Vaccination Programme. The start of vaccination under the new agreement is anticipated to occur in Q2/Q3 2019. There are five (5) minimum requirements for the vaccine. All the minimum requirements must be fulfilled. In addition to the information in KGV< the attached tender documentation provides information and rules for the competition.
Vis mer
Estimert verdi eksklusive mva: 74 000 000 NOK 💰
Varighet: 48 måneder
Tilleggsinformasjon:
With reference to point II.2.7 about Duration etc. the Norwegian Institute of Public Health emphasises that the agreement duration of 48 months, is a maximum length, but the agreement can be terminated earlier in accordance with provisions in the Supply Agreement (the Contract) point 14.
Vis mer
With reference to point II.2.6, the Norwegian Institute of Public Health emphasis that the stated value is the maximum value in a loosely estimated value range from NOK 48 million to NOK 74 million.
Utførelsessted
Hovedsted eller utførelsessted: Oslo.

Juridisk, økonomisk, finansiell og teknisk informasjon
Vilkår for deltakelse
Egnethet til å utøve yrkesvirksomheten:
The tenderer shall be registered in a company register, professional register or a trade register in the state where the tenderer is established.
Documentation requirement:
Norwegian tenderers: Company Registration Certificate.
Foreign tenderers: Verification showing that the tenderer is registered in a company register, professional register or a commerce register in the country where the tenderer is established.
Økonomisk og finansiell stilling:
Requirement: The tenderer shall have sufficient economic and financial capacity to be able to fulfil the contract. Creditworthiness with no requirement for guarantees will be sufficient to meet the requirement.
Documentation requirement:
Credit rating based on the most recent financial figures. The rating shall be carried out by a credit rating company with licence to conduct this service,
Teknisk og faglig kapasitet:
Requirement: The tenderer shall have experience from comparable assignments.
Documentation requirement:
Description of the tenderer's up to 3 most relevant contracts in the course of the last 3 years. The description must include an indication of the assignment product/scope or value, dates and recipients. It is the tenderer's responsibility to document relevance through the description.
Vis mer
Requirement: The tenderer shall have sufficient delivery capacity throughout the contract period.
Confirmation that the tenderer has the capacity to deliver a sufficient number of doses of the rotavirus vaccine to fulfil the contract.
Requirement: The tenderer shall have the requisite permissions to be able to fulfil the contract.
If the tenderer is the manufacturer of the vaccine, permission must be presented from relevant EU/EEA authorities to manufacture pharmaceuticals.
If the tenderer is not the manufacturer of the vaccine, the requisite permissions from relevant EU/EEA authorities to trade in pharmaceuticals must be presented.
If the tenderer imports the vaccine, the import license that includes the offered vaccine must be presented.
Kontraktutførelse
Vilkår for kontraktoppfyllelse:
— The Norwegian Institute of Public Health requires ethical and socially responsible production. (Supply Agreement, point 10, 10.1 – 10.4).
— The tenderer shall be a member of the Legemiddelansvarsforeningen [Pharmaceutical Liability Association] (Supply Agreement, point 9.2).
— Folkehelseinstituttet [the Norwegian Institute of Public Health] can re-sell, non-distributed, vaccine doses (Supply Agreement, point 15.1).
— First delivery: A sufficient number of doses necessary to complete immunisation of 15 000 infants by 31.3.2019 (Supply Agreement, point 3.6).
— Tenderers are obligated to deliver the necessary number of doses for complete immunisation of 65 000 infants per calendar year. (Supply agreement point 3.3).
— Folkehelseinstituttet [the Norwegian Institute of Public Health] is obliged to purchase a minimum volume of the sufficient number of doses necessary to complete immunisation of 50 000 infants per calendar year during the agreement period. (Supply agreement point 3.2).
Vis mer

Prosedyre
Tidspunkt for mottak av tilbud: 13:00
Språk som tilbud eller forespørsler om deltakelse kan sendes inn på: engelsk 🗣️
norsk 🗣️
Tilbudets gyldighetsperiode: 2018-11-15 📅
Dato for åpning av tilbud: 2018-08-21 📅
Tidspunkt for åpning av tilbud: 13:30
Sted: The Norwegian Institute of Public Health, Oslo Tenders will be opened electronically in the Tender Management Tool.
Tilleggsinformasjon:
Two employees from the Norwegian Institute of Public Health’s Unit for Vaccine Supply, or the legal department.
Tildelingskriterier
Kvalitetskriterium (navn): Quality, including safety and effect
Kvalitetskriterium (vekting): 50
Vekting av pris: 50

Oppdragsgiver
Identitet
Nasjonalt registreringsnummer: 983 744 516
Kontakt
Kontaktpunkt: Ole Andreas Fuglesang
Adresse til kjøperprofilen: https://eu.eu-supply.com/ctm/Company/CompanyInformation/Index/346372 🌏
URL for dokumenter: http://eu.eu-supply.com/app/rfq/rwlentrance_s.asp?PID=213693&B=DFO 🌏

Utfyllende informasjon
Klageinstans
Navn: Klagenemnda for offentlige anskaffelser (KOFA)
Postadresse: Postboks 511 Sentrum
Poststed: Bergen
Postnummer: 5805
Land: Norge 🇳🇴
Internettadresse: https://www.kofa.no/ 🌏
Kilde: OJS 2018/S 113-258404 (2018-06-14)
Kunngjøring om tildeling av kontrakt (2018-12-13)
Gjenstand
Anskaffelsens omfang
Kort beskrivelse:
Publication of contract award. The Norwegian Institute of Public Health has held an open tender competition for the procurement of vaccines against the rota virus for the base vaccination of infants in the Norwegian child vaccination programme, starting in Q2 2019. The competition was held as an open tender competition, a one-step process where all interested tenderers can submit a tender. Negotiations were not allowed. The objective of the procurement was to enter into a contract for the delivery of the rota virus vaccines for base vaccination of infants in the Norwegian Child Vaccination Programme. The start of vaccination under the new agreement is anticipated to occur in Q2/Q3 2019. The procurement was first announced on 1.6.2018 and then cancelled on 7.6.2018. The Doffin reference numbers to the cancelled competition are 2018-088615 and 2018-347723 respectively. The reasons for the cancellation are in the Doffin notice.
Vis mer
Totalverdi for anskaffelsen: 74 000 000 NOK 💰
Metadata for kunngjøring
Dokumenttype: Kunngjøring om tildeling av kontrakt

Prosedyre
Tilbudstype: Ikke aktuelt

Referanse
Datoer
Sendt dato: 2018-12-13 📅
Publiseringsdato: 2018-12-14 📅
Identifikatorer
Kunngjøringsnummer: 2018/S 241-552032
Refererer til kunngjøring: 2018/S 113-258404
OJ-S-utgave: 241
Tilleggsinformasjon
With reference to point II.2.7 about Duration, etc. the Norwegian Institute of Public Health emphasises that the agreement duration of 48 months, is a maximum length, but the agreement can be terminated earlier in accordance with provisions in the supply agreement (the contract) point 14. With reference to point II.2.6, the Norwegian Institute of Public Health emphasis that the stated value is the maximum value in a loosely estimated value range from 48 000 000 NOK to 74 000 000 NOK.
Vis mer

Gjenstand
Anskaffelsens omfang
Kort beskrivelse: Publication of contract award.
The Norwegian Institute of Public Health has held an open tender competition for the procurement of vaccines against the rota virus for the base vaccination of infants in the Norwegian child vaccination programme, starting in Q2 2019. The competition was held as an open tender competition, a one-step process where all interested tenderers can submit a tender. Negotiations were not allowed. The objective of the procurement was to enter into a contract for the delivery of the rota virus vaccines for base vaccination of infants in the Norwegian Child Vaccination Programme. The start of vaccination under the new agreement is anticipated to occur in Q2/Q3…
… 2019.
… 2019. There were five (5) minimum requirements for the vaccine. All the minimum requirements had to be fulfilled.
Tilleggsinformasjon:
With reference to point II.2.7 about Duration, etc. the Norwegian Institute of Public Health emphasises that the agreement duration of 48 months, is a maximum length, but the agreement can be terminated earlier in accordance with provisions in the supply agreement (the contract) point 14.
Vis mer
With reference to point II.2.6, the Norwegian Institute of Public Health emphasis that the stated value is the maximum value in a loosely estimated value range from 48 000 000 NOK to 74 000 000 NOK.
Utførelsessted
Hovedsted eller utførelsessted: Oslo

Prosedyre
Tildelingskriterier
Pris (vekting): 50

Tildeling av kontrakt
Dato for kontraktinngåelse: 2018-10-09 📅
Navn: GlaxoSmithKline AS
Nasjonalt registreringsnummer: 930744516
Postadresse: PO Box 180 Vinderen
Poststed: Oslo
Postnummer: 0319
Land: Norge 🇳🇴
Totalverdi for anskaffelsen: 1 NOK 💰
Informasjon om tilbud
Antall mottatte tilbud: 1

Referanse
Tilleggsinformasjon
The Contracting Authority has calculated a contract value and reports that the real contract value is within the interval stated in the notice (48 000 000 NOK — 74 000 000 NOK).
The actual contract value will not be made public as the Contracting Authority believes that, since the competition´s only price element was price per dose, it would, based on other information given in the tender documentation and the actual contract value, be possible to calculate the chosen tenderer's offered price per dose.
Vis mer
Furthermore, the Contracting Authority believes that price per dose is confidential information and therefore exempt from publicity in accordance with Freedom of Information Act § 13 and the Public Administration Act § 13, 2).
Kilde: OJS 2018/S 241-552032 (2018-12-13)
Nye anskaffelser i relaterte kategorier 🆕
Relaterte søk 🔍
Produkter/tjenester:
Medisinsk utstyr, legemidler og utstyr... Farmasøytiske produkter Antiinfektive midler for systemisk bruk,... Antiinfektive midler for systemisk bruk Vaksiner